PDS Biotechnology Corporation

(PDSB) Trade

By |

Profile

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Contact Information

Website: www.pdsbiotech.com
Email: tbui@theruthgroup.com
Main Phone: +1 800 208-3343
Address: 300 Connell Drive
Address 2: Suite 4000
State: NJ
City / Town: Berkeley Heights
Country: US
Postal Code: 07922

Issuer Information

Exchange: NSC
CEO: Frank Bedu-Addo
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Contact Information

Website: www.pdsbiotech.com
Email: tbui@theruthgroup.com
Main Phone: +1 800 208-3343
Address: 300 Connell Drive
Address 2: Suite 4000
State: NJ
City / Town: Berkeley Heights
Country: US
Postal Code: 07922

Issuer Information

Exchange: NSC
CEO: Frank Bedu-Addo
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 2.12 $ 0.16 (8.16%)
Last Price 2.12 Change $ 0.16 Change % 8.16 Tick N/A
Bid 2.09 Bid Size 100.00 Ask 2.10 Ask Size 4,300.00
Open 1.96 High 2.18 Low 1.94 Prev Close 1.96
Last Trade Volume 433,653 52 Wk Hi 4.99 52 Wk Low 0.62
Market Cap 47.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 22,261,619.00 EPS (TTM) -1.63 PE Ratio -1.20 Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 11 11
Number of Buys 11 11
Number of Sells 0 0
Net Activity 391797 391797
Last 10 Buys Shares
James J. Loughlin 1,000
James J. Loughlin 1,000
James J. Loughlin 1,000
James J. Loughlin 1,000
James J. Loughlin 1,000
James J. Loughlin 1,000
James J. Loughlin 1,000
James J. Loughlin 1,000
James I. Healy 1,000
James I. Healy 1,000
Last 10 Sell Shares
R. Loch Macdonald 1,000
R. Loch Macdonald 1,000
R. Loch Macdonald 1,000
R. Loch Macdonald 1,000
Brian A. Leuthner 1,000
Brian A. Leuthner 1,000
Brian A. Leuthner 1,000
R. Loch Macdonald 1,000
Brian A. Leuthner 1,000
R. Loch Macdonald 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 21 21 21 21
Low Target Price Estimate 21 21 21 21
Mean Target Price Estimate 21 21 21 21
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 03/01/18 03/01/18 03/01/18 03/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1